Understanding the National Healthcare Ecosystem to Position Medical Affairs as a Strategic Element: Lessons Learned from AstraZeneca Spain

This research underscores the essential role of MA departments in redefining their influence within healthcare systems. By aligning MA activities with stakeholder trends, pharmaceutical companies can reposition MA as a central pillar within the healthcare ecosystem. Our assessment of the Spanish health system provides a strategic framework that can be easily implemented by other MA departments in the industry to adapt to evolving stakeholder dynamics worldwide.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Medicine
Published
2024-12-23
DOI
https://doi.org/10.1007/s40290-024-00542-x
Citations
8
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
9.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding the National Healthcare Ecosystem to Position Medical Affairs as a Strategic Element: Lessons Learned from AstraZeneca Spain

M. Boronat Cortés, Inmaculada Iglesias, Jorge A. Marinich, Lucía Regadera Anechina et al.
8 citations
Pharmaceutical Medicine
Health Systems, Economic Evaluations, Quality of Life
9.03
article

Understanding the National Healthcare Ecosystem to Position Medical Affairs as a Strategic Element: Lessons Learned from AstraZeneca Spain

M. Boronat Cortés, Inmaculada Iglesias, Jorge A. Marinich, Lucía Regadera Anechina, Ana Pérez Domínguez
article en
8 citations

Abstract

This research underscores the essential role of MA departments in redefining their influence within healthcare systems. By aligning MA activities with stakeholder trends, pharmaceutical companies can reposition MA as a central pillar within the healthcare ecosystem. Our assessment of the Spanish health system provides a strategic framework that can be easily implemented by other MA departments in the industry to adapt to evolving stakeholder dynamics worldwide.

Pharmaceutical MedicineVol. 39(1)
AstraZeneca (Spain) (ES)
Industry, innovation and infrastructure
Openalex Percentile: Top 3%
Health Systems, Economic Evaluations, Quality of Life
9.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.